IGC logo

IGC
IGC Pharma Inc

30,206
Mkt Cap
$34.67M
Volume
1.00
52W High
$0.4985
52W Low
$0.2525
PE Ratio
-4.70
IGC Fundamentals
Price
$0.377
Prev Close
$0.3794
Open
$0.3745
50D MA
$0.4046
Beta
0.49
Avg. Volume
715,776.90
EPS (Annual)
-$0.0931
P/B
5.22
Rev/Employee
$18,157.14
Loading...
Loading...
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
70

Frequently Asked Questions

What is Market Cap of IGC Pharma Inc?
What is the 52-week high for IGC Pharma Inc?
What is the 52-week low for IGC Pharma Inc?
What is IGC Pharma Inc stock price today?
What was IGC Pharma Inc stock price yesterday?
What is the PE ratio of IGC Pharma Inc?
What is the Price-to-Book ratio of IGC Pharma Inc?
What is the 50-day moving average of IGC Pharma Inc?
How many employess does IGC Pharma Inc has?

Latest IGC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.